H. Paradis et al., DIFFERENTIATION RESPONSES OF EMBRYONIC ENDOTHELIUM TO LEUKEMIA INHIBITORY FACTOR, Experimental cell research, 240(1), 1998, pp. 7-15
The IEM cell line is a murine embryonic endothelial cell line that res
ponds to combinations of basic fibro blast growth factor (bFGF) and le
ukemia inhibitory factor (LIF) by undergoing proliferation and vasculo
genic differentiation in vitro and in vivo. Exposure to LIF and bFGF i
n vitro permits the IEM cells to specifically chimerize endothelium in
vivo and recapitulate normal endothelial development after blastocyst
injection. We report here that unmanipulated IEM cells form vascular
neoplasias when injected into immunodeficient nude mice. Examination o
f IEM neoplasia following exposure in vitro to bFGF and LIF before inj
ection into nude mice profoundly reduced or completely suppressed the
neoplastic growth of IEM cells. Furthermore, this suppression was obse
rved by treatment with LIF alone, while bFGF treatment did not signifi
cantly alter IEM neoplasia and did not modify the LIF-mediated suppres
sion. Characterization of the IEM responses to LIF revealed that the L
IF suppression of IEM neoplasia depended on how long the cells were ex
posed to LIF in vitro. The IEM cell response to LIF was associated wit
h the specific activation of the transcription factor Stat3. Stat1 act
ivation could not be detected in response to LIE, although it is expre
ssed in IEM cells. Our results demonstrate that the LIF-induced differ
entiation of IEM cells involves suppression of IEM-derived neoplasia a
nd is associated with the specific activation of Stat3. (C) 1998 Acade
mic Press.